Ex-House Majority Leader Eric Cantor seeks to address pharmaceutical industry issues in Washington
In Washington, Eric Cantor will confront bipartisan backlash over rising health care costs.
Headlines here are rewritten to state the actual fact, and each story is summarized into a few plain bullets by an LLM — so you can skim the news without clicking bait. Stories covered by several outlets are merged into one card. Anything you open or dismiss won't come back.
Thursday
Study finds GLP-1 prescriptions for children with obesity rare, reserved for severe cases
- Researcher found GLP-1 prescriptions for children ages 8-11 increased 310-fold since 2019, but only 0.6% of 3.5M obese children received them
- 94% of children prescribed GLP-1s had severe obesity with serious complications: sleep apnea, prediabetes, hypertension, or fatty liver disease
- Childhood severe obesity increases risk of chronic kidney disease 9-fold and fatty liver disease mortality 40-fold by young adulthood
- Author argues both evidence-based treatment for severely ill children AND systemic reforms (beverage taxes, nutrition standards) are necessary
- No GLP-1 drugs are currently FDA-approved for children under 12, limiting access and insurance coverage
NSW crushes 23 illegal ebikes as hospital reports 22% surge in riding injuries
- NSW crushed 23 illegal ebikes on Thursday; 36 seized total under regulations effective August limiting ebikes to 25km/h and 500W power
- St Vincent's hospital reported 361 ebike-related injuries Jan-July 2026, a 22% increase from 296 the prior year
- 42% of injuries required trauma response; majority involved riding impaired, speeding, or without helmets
- Documented injuries include fractures, internal bleeding, organ perforation, and severe brain trauma
- Government considering age restrictions (12-16 years) after incidents including ~40 ebikes swarming Sydney Harbour Bridge in February
DR Congo politician beaten to death after defending Ebola response
- Marie-Celestin Karondwa, a local politician in Butembo, was beaten at his home on Sunday and died Wednesday from his injuries
- His party said he was attacked for publicly supporting the government's Ebola response on radio; his house was set on fire
- The attack's perpetrators remain unknown; unclear what motivated the violence
- Part of escalating violence against health workers during DRC's deadliest Ebola outbreak: 8,000+ cases, nearly 4,000 deaths
- Widespread distrust of government and conspiracy theories about Ebola are hampering outbreak response efforts
Woman's infected pacemaker replaced with leadless implant to avoid wound complications
- 63-year-old woman from Jammu with complete heart block received conventional pacemaker implant
- Pacemaker site became infected despite antibiotics; cultures identified Acinetobacter and Enterobacter bacteria
- Infected device and leads surgically removed; patient had complicating factors (uncontrolled diabetes, steroid use, prior amputation)
- Replacement: AVEIR leadless pacemaker implanted directly into heart via femoral catheter, eliminating need for chest pocket
- Recovery: Patient mobile within 6 hours, discharged next day; leadless approach reduces infection risk for high-risk patients
Supreme Court targets pricing gap letting hospitals mark up cancer drugs by 1,000%
- Supreme Court identified pricing scheme where hospitals mark up cancer drugs by up to 1,000% between manufacturer cost (PTR) and retail price (MRP)
- Manufacturers offer low prices to hospitals while setting high retail caps, allowing hospitals to pocket the difference and incentivizing expensive over cheaper brands
- 2013 Drug Prices Control Order caps retail prices but not hospital markups; a 2019 NPPA trial capping margins at 30% reduced cancer drug prices by up to 91%
- Patients cannot shop around (private hospitals restrict off-site pharmacy purchases) and often skip doses due to unaffordable costs, affecting treatment adherence
- Court recommends fixed percentage markups with regressive rates (smaller percentages for expensive drugs) to prevent hospitals from preferring high-cost options
Wednesday
32+ Baiga children died of measles, malaria in remote Madhya Pradesh villages
- 32 children (ages 3 months–18 years) from Baiga tribal villages in Balaghat district died between May and September
- Deaths attributed to measles (8–10 cases) and malaria (~10 cases), worsened by severe malnutrition
- Remote terrain and cultural beliefs around disease goddesses delayed medical treatment by weeks
- Nearest hospital is 70km away; families earn ~$2/day and lack vehicles for emergency transport
- Malnutrition widespread due to poverty, early motherhood, and diet limited to rice and lentils
Pennsylvania measles deaths reach 5; state has 943 cases amid worst US outbreak since 1991
- Fifth measles death confirmed in Lancaster County, PA; deceased was unvaccinated
- Pennsylvania: 943 confirmed cases across 39 counties, 176+ hospitalized; cases doubled since August
- Worst US measles outbreak since 1991; disease resurgence linked to rising vaccine skepticism
- Outbreak centered in Lancaster County's Amish and Mennonite communities with low vaccination rates
- Vaccination surge: 53,000+ MMR doses given in September, more than double normal monthly rate
Trump Medicare drug pricing rule narrowed to 4 companies
- Trump administration finalizes GLOBE pilot program requiring four drug companies to offer Medicare prices matching levels in other wealthy nations
- Final rule is significantly narrower than initial proposal, covering only 4 companies instead of broader set
- Drug companies with existing voluntary Medicaid pricing deals are exempt from the GLOBE program
- Part of broader most-favored nation (MFN) pricing effort; second pilot program (GUARD) remains in proposed stage
Trump administration begins sending $500 refunds to 950,000 Obamacare enrollees over disputed Biden-era charges
- Treasury Department started Sept. 30 sending $500 refunds to 950,000+ Obamacare enrollees in 30 federal-exchange states; some recipients receiving multiple checks.
- Primary recipients earned over 400% of federal poverty line ($63,000 individual, $129,000 family of four) and lost enhanced premium subsidies in 2026.
- Refunds funded by CMS user fees on health insurers; Trump administration claims Biden-era fees were excessive and passed to consumers via higher premiums.
- Health policy experts say $500 barely offsets actual premium increases and describe announcement as political strategy for 2026 Congressional elections.
At least 5 measles deaths reported among unvaccinated; CDC reports only 2
- At least five measles deaths reported among unvaccinated people in 2024; CDC officially reporting only two.
- 3,659 measles cases in U.S. in 2024, highest since 1991; disease was declared eliminated in 2000.
- Vaccination rates declining amid anti-vaccine misinformation; vaccination exemptions at all-time high.
- Pennsylvania administered 8,500+ MMR vaccine doses in 2024, including 5,500+ at outbreak clinics.
Highly effective HIV prevention method raises access equity questions
A twice-yearly injection could revolutionise HIV prevention, but who gets access raises bigger questions.
HHS launches SURPASS, five-year AI program to redesign clinical trials
- HHS announced SURPASS ('Simulation-augmented, Real-time Platform Adaptive Seamless Trials'), a five-year program through the Advanced Research Projects Agency for Health (ARPA-H).
- Initiative uses AI and computational models to speed up trials and replace rigid multi-phase structures with adaptive approaches.
- Program accepting applications from cross-disciplinary teams in statistics, AI, and clinical trial design starting later this fall.
- Initial announcement omitted funding amounts and details on resources or flexibility offered to trial participants.
Bangladesh Dengue Outbreak Surpasses 233 Deaths
Bangladesh’s health authorities report that at least 233 people have died from dengue fever.
Frequent painkiller and antibiotic use can silently damage kidneys without early symptoms
- CDSCO warned against indiscriminate use of NSAIDs and antibiotics; kidney damage can occur without noticeable warning signs until function declines significantly
- Regular painkiller use (several times per week) increases kidney injury risk, especially for those dehydrated, older, diabetic, or with existing kidney disease
- Some antibiotics are directly toxic to kidney cells or trigger inflammatory reactions; commonly misused for viral infections where they're ineffective
- High-risk groups (existing kidney disease, pregnant women, young children, heart failure/liver disease patients) face greater harm from self-medication with these drugs
- Medical experts recommend identifying and treating the underlying cause of recurring pain rather than suppressing it with chronic medication use
The rise of fibermaxxing: How GLP-1 usage and colon cancer fears fuel fiber trend
- 95% of Americans lack sufficient fiber intake; surge driven by 11% of US population now using GLP-1 drugs (up from 3% in 2024) and rising colorectal cancer in people under 50
- Colorectal cancer deaths in under-50s rising 1.1% annually since 2005; 45% of new diagnoses now in people under 65, compared to 27% in 1995
- Fiber (soluble and insoluble types, 25-38g daily recommended) aids digestion, cholesterol, blood glucose, and colorectal cancer prevention—but supplement overuse risks gas and medication interference
- Fibermaxxing trend warns against excessive intake (60-100g daily) and fiber supplements unbalanced toward soluble types, which can cause digestive distress if increased too quickly
Hundreds of thousands of legal immigrants losing Medicaid starting October 1 under new U.S. law
- Legally present immigrants including refugees, asylees, trafficking victims, and Afghan interpreters losing Medicaid Oct. 1, 2026, under Trump's One Big Beautiful Bill Act passed in 2025.
- At least 281,000 immigrants identified across nine states and D.C. losing coverage; Florida (177,000), Arizona (28,000), New Jersey (15,000-25,000) see largest impact; additional 1M to lose ACA subsidies and 100K to lose Medicare by 2034.
- Coverage retained only for: green card holders, immigrants under 19, and citizens of Cuba, Haiti, certain Pacific Island countries.
- California, New York, Pennsylvania using state funds for replacement coverage; California allocating $365M through July 2027 to maintain health access.
- Loss eliminates access to preventive care, specialists, and medications; only emergency care through Emergency Medicaid remains available.
Eli Lilly's combo obesity drug shows 23.3% weight loss in Phase 2 trial
- Eli Lilly's combination of eloralintide (amylin-targeting) and low-dose tirzepatide achieved 23.3% average weight loss (54 lbs) in 48-week Phase 2 trial versus 14.8% (34.4 lbs) for tirzepatide alone
- The three-hormone approach targets GLP-1, GIP, and amylin pathways simultaneously to suppress appetite, comparing to dual-pathway drugs currently on market
- Blood sugar levels (A1C) improved by up to 2.9% on combo therapy versus 2.4% for tirzepatide alone
- Dropout rate due to side effects was higher for combo (10.8–27%) than tirzepatide alone (2.9%), with gastrointestinal issues being most common but generally mild-to-moderate
- Phase 3 trials planned for end of 2026; Lilly also developing single-injection co-formulation to simplify patient administration
Failed Tennessee execution after 1+ hour sparks doctors' demand for medical ethics overhaul
- Tony Carruthers' May 2025 execution attempt at Riverbend prison failed after >1 hour of unsuccessful needle attempts to establish IV access; Gov. Bill Lee halted it and granted a reprieve.
- Over 40 Tennessee doctors and nurses demanded executions be halted and healthcare workers removed from the process, citing violations of medical ethics standards.
- AMA code explicitly bars physician participation in executions; Tennessee's protocol requires doctors, pharmacists, and nurses—contrary to established medical ethics.
- The assigned physician hasn't performed central line placements in 12 years; his untrained attempt caused pain and bleeding but ultimately failed.
- A second execution scheduled for Sept. 30 was halted hours before; the inmate's attorneys cited her platelet disorder and raised competency concerns based on Carruthers' case.
Eli Lilly's Zepbound + amylin drug combination: 23.3% weight loss in 48 weeks
- Eli Lilly combined Zepbound (GLP-1) with eloralintide (amylin drug) in patients with obesity and type 2 diabetes
- 23.3% weight loss at highest dose after 48 weeks, vs 14.8% for Zepbound alone and 11.1% for eloralintide alone
- Results presented at European Association for the Study of Diabetes annual meeting
- Combination notably more effective for diabetic patients, who typically lose less weight from medications
- High treatment discontinuation rates suggest tolerability concerns
CDC reports 2 measles deaths while Pennsylvania counts 4 in 2025 outbreak
- CDC reports 2 measles deaths in U.S. this year; Pennsylvania reports 4 in an outbreak
- Dispute centers on whether deaths should be counted 'from' vs 'with' measles
- Unclear which Pennsylvania deaths CDC counted in its update
- RFK Jr.'s misleading vaccine claims create public confusion; 40% unsure of his measles stance
U.S. measles outbreak reaches 3,600+ cases with exposures on transit and at events
- The U.S. has 3,600+ confirmed measles cases as of Sept. 24, 2026, the worst resurgence in decades
- Recent exposures traced to trains, buses, bars, and sports stadiums; Pennsylvania, Ohio, and New York most affected
- One unvaccinated person with measles can infect 15–18 susceptible people through airborne transmission
- CDC recommends two doses of MMR vaccine; nearly all cases occur in unvaccinated individuals
- Measles can cause lasting damage including 'immune amnesia,' reducing immunity to other infections
Wegovy pill led to additional 4% weight loss in patients switching from obesity injections
- 194 telehealth patients (56% female) switched from Wegovy or Zepbound injections to Novo's Wegovy pill
- After 3 months on pill: average 4% body weight loss (8.8 lbs from 221 lb baseline); 40% lost 5% or more
- 75% of patients satisfied with pill; 82% reported improvements including better-fitting clothes
- Study limitations: real-world telehealth data with incomplete collection, self-reported measurements
5/3/1 strength program: Four-week cycle with decreasing reps and increasing weight for gains
- Jim Wendler's program uses 4 compound exercises (squat, bench press, deadlift, overhead press) over 4 weeks
- Weekly rep progression: 5 reps (week 1) → 3 reps (week 2) → 5-3-1 combo (week 3) → deload (week 4)
- Gradually increases weights based on training max; requires prior strength-training experience
- Can include accessory exercises tailored to goals (legs, back, arms, core)
- Not suitable for beginners, injury recovery, or those seeking endurance/mobility training
Teen founded youth volunteer program serving 4,000+ seniors after nursing home rejection
- Jiya Joshi founded Young and Old United after being rejected from volunteering at age 14 due to age restrictions; convinced one nursing home director to give her a trial visit
- In 2 years, program grew to 70+ youth volunteers making regular nursing home visits across 11+ countries
- Helped 4,000 seniors through visits, spa days, and hygiene kit distributions; raised $9,000; partnered with United Airlines
- Addresses senior isolation—affecting 1 in 4 Americans 65+—through intergenerational friendship and activities
Access and affordability barriers limit patient use of new cancer drugs
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Family sued care facility that evicted dementia patient over antipsychotic medication dispute
- Marjorie Tingley, 85, displayed aggressive behavior at Vista Grande Villa; facility demanded antipsychotic medication to sedate her
- Sons refused, citing FDA warnings of increased death risk; families often face 'medicate or eviction' pressure at care facilities
- Facility called 911 repeatedly, transported Tingley to ER 8 times, then evicted her; she died in January 2025
- Family sued for negligence and wrongful eviction; federal study shows 1 in 4 Medicare beneficiaries with dementia receive potentially inappropriate antipsychotics
NPR investigation: children with disabilities represent largest foster care group with worst outcomes
- NPR analyzed 505,591 foster children in 2025; disabled youth stay 50% longer in care and are least likely to be reunited with families
- Disabled children form the largest group in foster care (25-80% depending on definition), with up to 80% having behavioral health disabilities
- 10% of disabled foster children live in institutional settings like group homes or psychiatric facilities—double the rate for non-disabled peers
- Disabled foster children average 4.6 placement moves vs 2.7 for others; those with physical disabilities die at 9x the rate
- Case example: 15-year-old Christian Williams died of diabetes complications in a residential facility where staff reported having no diabetes training
Montana enforces Medicaid work requirements starting Oct 1; confusing notices raise coverage concerns
- Montana begins enforcing Medicaid work requirements Oct 1: beneficiaries must work/volunteer/study ≥80 hours/month or qualify for exemptions (medically frail, primary caregivers)
- ~71,000 Montanans affected; state's confusing letters gave conflicting compliance deadlines, leaving many uncertain whether they'd lose coverage
- State understaffed: only ~20 of 59 planned staff positions filled; computer system to auto-verify student enrollment delayed until next year
- Support network collapsed: Cover Montana nonprofit shrunk from 18 to 2 staff after losing federal funding; state helpline severely backlogged
- Historical precedent: 2023 Medicaid redetermination dropped ~87,000 Montanans over paperwork errors; advocates warn new rollout will repeat the problem
DEA proposes banning 7-OH; experts disagree on kratom regulation strategy
- DEA proposed Schedule I classification for 7-OH (potent kratom derivative) in July 2025, while allowing natural kratom to remain unregulated
- Expert consensus: regulation needed; disagreement on approach—DEA ban vs. regulated marketplace; concerns include withdrawal, criminal prosecution, and research barriers
- Public comment period ended Sept 10 with ~36,000 submissions; DEA rule not yet finalized
- Two University of Mississippi students died this month with kratom products found at scenes; causal link unconfirmed
- Utah and West Virginia implemented strict regulations: third-party testing, specialty retail only, and 7-OH bans
Patna surgeon keeps consultation fee at Rs 10 for 40+ years, seeing 100+ patients daily
- Dr Ejaz Ali has charged Rs 10 for consultation since 1984—a fee unchanged for over four decades
- Sees more than 100 patients daily from across Bihar; appendix surgery with post-op medicines costs ~Rs 17,000
- Childhood poverty and mother's advice motivated his low-cost, high-volume practice model
- Waives surgical charges for some patients; allows installment payments for those unable to pay upfront
- His late wife was also a physician charging Rs 10; his three children (all doctors) charge between Rs 50–100
Flint schools' Musk-funded water filters now safe for student use after system redesign
- Elon Musk donated $480,350 in 2018 to install water filters at Flint schools following the water crisis
- Original filters (installed 2019-20) failed certification; redesigned system uses three-stage filtration with activated carbon, ultrafilter, and UV light
- 130 filtration stations now operational across 11 Flint schools; testing confirms no detectable lead post-filtration
- Pre-filtered water measured up to 620 ppb lead (EPA action level: 15 ppb); post-filtration tests show undetectable levels
New 6-month TB treatment threatened by emerging drug resistance
- WHO approved a new 6-month bedaquiline-based TB treatment in 2022, replacing a 20-month injection regimen with fewer side effects
- Drug-resistant TB strains are already emerging against the new treatment, threatening to reverse clinical progress
- TB killed 1.23 million people in 2024; surveillance and genomic sequencing needed to detect resistance patterns
- Researchers lack full understanding of how drug resistance develops, making it difficult to optimize long-term treatment strategies
Study confirms tau spreads like infectious prion proteins in the brain
- Human tau fibrils injected into mice caused normal mouse tau to misfold identically, proving tau acts as a prion-like template
- Confirms tau self-propagates similarly to infectious prion proteins in neurodegenerative diseases like Alzheimer's
- Published September 30, 2026 in Nature by UCLA researchers (Lövestam et al.); provides structural evidence for propagation hypothesis
- Understanding how tau self-replicates at atomic level could enable new therapeutic strategies for tauopathies
Brain cancer damages lymphatic vessels, weakening immune response
- Cancer spreading to the dura (brain's outer membrane) recruits osteoclasts, cells that degrade bone
- These osteoclasts damage meningeal lymphatic vessels that drain fluid from around the brain
- The vessel damage disrupts local anti-tumor immune responses, allowing tumors to evade detection
- Nature study (Sept 2026) identifies new therapeutic targets for dural metastases
Study finds sugar intake worsens antibiotic damage to gut bacteria in transplant patients
- Researchers tracked daily meals and stool samples from 173 blood cancer patients hospitalized for cell transplantation, collecting 9,419 meal records and 1,009 stool samples
- Patients who consumed more sweets during antibiotic treatment showed lower gut microbiome diversity and increased Enterococcus bacteria (a harmful pathobiont)
- Mouse studies confirmed that dietary sugar supplementation exacerbated and prolonged antibiotic-induced bacterial overgrowth
- Finding suggests short-term sugar avoidance during antibiotic courses could preserve beneficial gut bacteria and potentially improve clinical outcomes
FDA approves first gene therapy for rare genetic hearing loss, restores hearing in 42% of trial patients
- FDA approved Otarmeni in April 2025 as the first gene therapy for DFNB9, a rare genetic hearing loss caused by OTOF gene mutation.
- In CHORD clinical trials with 24 children, 80% experienced improved hearing within 24 weeks; 42% fully regained normal hearing.
- DFNB9 affects 1-8% of babies born with hearing loss; previously had no genetic cure other than cochlear implants approved in 2000.
- Therapy works by delivering functional OTOF gene copies to inner ear cells via modified viral vectors to restore sound signal transmission.
Human neurodegenerative disease tau strains transmit to mice, preserving disease-specific pathology
- Researchers injected tau protein fibers extracted from human brains with Alzheimer's disease and corticobasal degeneration into mice
- Nine months later, mice developed tau pathology matching the original human disease patterns, but composed of mouse tau, not human
- Alzheimer's-seeded mice showed pathology in neurons; corticobasal-seeded mice showed pathology in both neurons and glial cells
- Mouse tau filaments had identical atomic structures to the injected human seed fibers, proving tau conformations self-propagate faithfully
- The findings establish tau as a prion-like agent where different disease strains drive disease-specific pathology through templated seeding
Tuesday
Eli Lilly's Retatrutide shows up to 25% weight loss in clinical trials
- Retatrutide is a new obesity drug from Eli Lilly that targets three hormones (GLP-1, GIP, glucagon) to regulate appetite and metabolism
- Trial participants lost up to 25% of their body weight
- Builds on existing medications tirzepatide (Zepbound/Mounjaro) and semaglutide (Ozempic/Wegovy) by adding glucagon to the hormone combination
- Works by reducing insulin resistance, delaying stomach emptying, and triggering fullness signals in the brain
Trump rule requiring customs brokers for imported meds faces congressional opposition
- New Trump administration rule effective next month requires imported medicines to go through customs with a licensed broker and entry bond
- Congressional lawmakers urge reconsideration, saying the rule will increase costs and barriers for Americans importing cheaper prescriptions from Canada and overseas
- Americans have imported medicines from Canada for two decades as domestic prescription prices rose, but personal medicine imports are currently illegal under most circumstances
- The rule adds financial and administrative burden to importation that previously allowed Americans relatively easy access to lower-cost medications
Corn silk increases urine flow but isn't a treatment for kidney disease, expert says
- Corn silk does have diuretic properties that increase urine output, which may help prevent new kidney stones from forming
- It cannot dissolve existing stones or treat kidney disease; adequate water intake remains the primary prevention tool
- While it may reduce UTI risk through increased urine flow, it should never replace antibiotics for confirmed infections
- Safety concerns: lowers blood potassium, should not be combined with prescription diuretics, and should be avoided by those with reduced kidney function
- Pregnant women should avoid concentrated doses, and people with corn allergies should avoid entirely
Wealthy Americans spend $250K/year on longevity clinics; doctors say evidence is thin
- ~800 U.S. longevity clinics charge $8K–$250K/year for memberships; popular treatments like NAD+ IV drips ($150–$1K/session) lack scientific backing.
- Full-body MRIs ($1K–$3K+) frequently detect harmless findings that trigger unnecessary follow-up procedures with financial and health risks.
- Longevity doctors recommend research-backed basics (exercise, whole-food diet, social connection), yet wealthy clients pay tens of thousands for unproven therapies.
- Demand concentrated in high-wealth areas (NYC, LA, San Francisco) through peer networks and boutique wealth advisor recommendations.
Infections caused 12% of 2024 cancers (2.3M cases); HPV and H. pylori are leading causes
- WHO-affiliated researchers found 2.3 million new cancer cases in 2024 (12% of global total) were caused by infections
- Helicobacter pylori bacteria caused 760,000 stomach cancers, mostly in eastern Asia; HPV caused ~750,000 cases including all cervical cancers
- Epstein-Barr virus linked to ~260,000 cancers; study identified 16 additional infectious agents as cancer-causing, including HIV and Merkel cell polyomavirus
- Canada's infection-linked cancer rate is ~4% (~7,000 cases/year), but HPV vaccination rates plateaued last year, threatening cervical cancer elimination goal
- Screening programs, vaccines (HPV, HBV), and antibiotics for H. pylori can prevent most infection-related cancers, but access varies significantly by region
Antibody blocking CXCR3 reduces Alzheimer's neurodegeneration in mice by 40%
- Washington University St. Louis team used CXCR3-blocking antibody to prevent T cell brain entry in Alzheimer's model mice
- Treated mice had 40% less brain tissue loss in memory regions and better memory test performance than untreated controls
- Study published in Neuron; researchers note unclear whether findings will translate to humans
- Approach could eliminate need for Alzheimer's drugs to cross blood-brain barrier, a major treatment challenge
UniQure's Huntington's gene therapy slowed disease by 44% but benefit waned and isn't statistically significant
- UniQure's one-time gene therapy (AMT-130) surgically implanted in brain slowed Huntington's disease progression by 44% vs. matched controls after four years
- Treatment benefit has waned compared to analysis from one year prior, raising durability concerns
- The 44% slowing difference was not statistically significant
- FDA began review of UniQure's marketing application amid the emerging data
- One-time implant therapy raised questions about long-term effectiveness beyond four years
Smartwatch detects 120 bpm resting heart rate in 23-year-old; leads to AVNRT diagnosis and treatment
- 23-year-old's smartwatch alerted elevated resting heart rate (~120 bpm) with no obvious cause
- Further investigation revealed 3.5-month history of palpitations and near-fainting episodes
- Diagnosed with AVNRT (abnormal heart rhythm); treated via radiofrequency ablation procedure
- Persistent elevated resting heart rate with accompanying symptoms warrants specialist evaluation regardless of age
- Smartwatches detect anomalies but cannot diagnose; medical consultation required for unusual sustained readings
Research challenges attention deficit as core mechanism of ADHD
Evidence suggests that it really affects what psychiatrists like me call sustained engagement — an important difference in understanding how to think about the condition.
Researcher's 20-year study finds vaccine-hesitant parents follow logical reasoning focused on individual child benefit
- Sociologist Jennifer Reich at University of Colorado spent two decades studying vaccine-hesitant families and found their decisions are rational, not anti-science
- Parents prioritize individual child benefit over population health impact; one mother rejected rubella vaccine for her son because males don't become pregnant
- Reich attributes vaccine hesitancy to cultural pressures teaching parents to make individualized health choices and 'work hard' to keep their children healthy through diet and lifestyle
- Parents understood population-level disease data but couldn't see how it applied to their specific child or family circumstances
- Reich advocates engaging with parents' legitimate concerns rather than dismissing them as misinformation or stupidity
Midterm elections could reshape drug pricing, Medicaid, and research funding policies
Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.
CMS ends special Medicare payments for FDA breakthrough devices
- Starting October, CMS eliminated supplementary Medicare payment pathways for FDA breakthrough-designated medical devices
- Since 2020, breakthrough devices received extra payments without proving clinical superiority; this exemption now ends
- Nearly 800 devices obtained FDA breakthrough status since 2022, including CT triage algorithms, UTI diagnostic panels, and thrombectomy robots
- Breakthrough designation will no longer provide automatic Medicare payment advantages; devices must now meet standard evidence requirements
Poor child health threatens military readiness and U.S. economic competitiveness
- 77% of young Americans fail military health screening; three military branches missed recruitment targets in fiscal 2023 due to health-related disqualifications
- American children are 1.8× more likely to die than children in other developed nations; 40% will face obesity, chronic illness, anxiety, or depression
- Childhood health problems reduce school achievement, workforce participation, and lifetime productivity—costing the nation economically
- Experts propose expanding healthcare access, nutrition support, early childhood programs, and poverty reduction as tested solutions
- 1960s policy response to similar crisis (expanded Medicaid, anti-poverty programs) successfully strengthened the workforce and national strength
Gaza's lab capacity collapses: 87% material shortage forces doctors to ration diagnostic tests
- Gaza's laboratories lack 87% of required materials; only 5 of 18 CT scanners operational; zero MRI services available
- Blood gas testing halted; automated chemistry analyzers and sterilization equipment non-functional from war damage
- Doctors forced to ration tests by severity—only kidney, cancer, cardiac, and ICU patients tested; others await indefinitely
- 350,000 chronic disease patients face medication shortages; Gaza's sole cancer hospital destroyed
- Hospital directors warn blood banks and labs risk complete shutdown, potentially fatal for cardiac and kidney patients
Monday
Maui wildfire study finds toxic metal contamination in residents up to 18 months later
- University of Hawaii study of 1,400 Maui residents found elevated toxic metals (arsenic, cadmium, antimony) in urine up to 18 months after August 2023 fires that killed 100+ people
- Metal levels dramatically higher than U.S. average: antimony 40x, manganese 3.8x, barium 2.3x, arsenic 2.2x higher in Maui residents
- Higher metal exposure correlated with reduced lung function and breathing capacity in participants, even well after fires ended
- Metals likely from burned buildings, vehicles, and electronics rather than just burned vegetation
Merck discontinues Recarbrio antibiotic citing limited market despite critical last-resort role
- Merck discontinued Recarbrio, a three-drug combination antibiotic approved in 2019 for serious infections
- Used to treat hospital-acquired pneumonia, complicated urinary tract infections, and stomach infections when alternatives fail
- FDA designated it last-resort treatment to prevent antibiotic resistance, which severely limited commercial demand
- Company provided no explanation and withheld sales figures, indicating weak market performance
- Highlights pharmaceutical industry's reluctance to develop antibiotics despite critical public health needs
Study: Drug patents per drug tripled since 1990, extending price protection
- JAMA study by University of Alabama researchers published Monday analyzed FDA-approved small-molecule drugs from 1990–2019
- Number of patents per drug increased from 2.1 (1990) to 6.9 (2019); most growth in 'nonprimary' patents for formulation tweaks and delivery devices
- Average patent protection period extended from 2 years (1990) to 6.1 years (2019), delaying generic drug competition
- Patent 'thickets' keep brand-name prices higher for longer without clinical advancement, limiting price competition
Study explores housing arrangements as potential solution to loneliness
Fresh pies. Book groups. Puzzle challenges. Developers of master-planned communities see fear of social isolation and desire for friends as a business opportunity. Welcome to Amity Lane.
Burning Man 2026: 3 deaths statistically normal for event's young, educated demographic
- Three deaths at Burning Man 2026—the highest recorded number in the event's 30+ year history
- Age-standardized analysis predicts 4.9 expected deaths for 70,000 attendees over one week; observing 3 falls within normal range (27% probability)
- Burning Man population skews significantly younger, more educated, and higher income than general US population—all factors associated with lower mortality
- Selection bias likely explains historically near-zero death rates: the event attracts healthier, physically capable people regardless of demographics
Gisèle Pelicot's daughter launches French campaign to help drugging and sexual assault victims come forward
- Caroline Darian launched a nationwide campaign Monday across French TV, social media, and posters urging victims of drug-facilitated sexual assault to report attacks
- Campaign features mother Gisèle Pelicot, 73, whose ex-husband Dominique Pelicot was convicted along with 50 other men for raping her while drugged
- In 75% of drugging assault cases, perpetrator is a family member or friend; victims urged to contact CRAFS center for evidence collection despite memory loss
- Darian founded Mendorspas association to combat victim shame and encourage reporting; campaign described as unprecedented for addressing the public health issue
Employer Health Insurance Expected to Worsen in 2027, Experts Warn
- Health insurance through employers is in a 'bleak state' with conditions deteriorating
- Experts predict 2027 will be worse than 2026 for employee health coverage
- Public-sector employers show concerning developments in benefits offerings
- Full analysis paywalled behind STAT+ subscription
AbbVie receives FDA approval for new Parkinson's disease treatment
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped improve symptoms.
Most foods contain some protein
We look at the market for products with added protein.